Immunotherapy refers to cancer treatments that help the immune system act against cancer. It includes several approaches rather than one medicine or one treatment experience.
Its suitability depends on the cancer type and the specific clinical setting. Ask your team what the proposed treatment is called and what evidence supports it for your diagnosis.
Different approaches have different roles
Examples include immune checkpoint inhibitors, treatments involving a patient's immune cells, and other immune-based therapies. Their schedules, preparation, and possible effects differ.
Some cancers have testing that helps guide a treatment choice. Ask whether your plan depends on a tumor marker, genetic change, or other laboratory finding and what the result means.
Do not confuse a general claim that a product “boosts immunity” with a tested cancer immunotherapy. A supplement or wellness product is not an equivalent substitute for a prescribed cancer treatment.
Start with the purpose
Ask whether the treatment is intended to reduce recurrence risk, control known disease, or serve another goal. Ask whether it will be combined with chemotherapy, surgery, radiation, or another medicine.
A treatment can be appropriate without benefiting every patient who receives it. Request an explanation of the expected benefit, the main uncertainty, and what alternatives were considered.
If treatment is offered through a trial, ask which aspects are investigational and how that changes the practical plan.
Monitoring during treatment
Your team may check symptoms, examinations, laboratory results, and scans. Ask how often assessments occur and when you will discuss whether the treatment should continue.
Keep a list of the exact treatment names and dates. If another clinician sees you, make sure they know you are receiving or have received immunotherapy.
Side effects and treatment response are separate questions. The presence or absence of a side effect is not a dependable way to judge cancer response.
Report new symptoms
Some immunotherapies can cause inflammation in healthy organs. The possible effects depend on the treatment, and symptoms may occur during treatment or after it has ended.
Get a written contact plan before the first dose. Ask about reporting new breathing problems, diarrhea, rash, marked weakness, or other changes relevant to your regimen.
Do not assume a new symptom is unrelated because the last treatment was some time ago. Tell the evaluating clinician the treatment name and timing, and follow the oncology team's instructions about contacting them.
Medicines and practical preparation
Share your full medication list, including steroids, other immune-affecting medicines, and supplements. The team should interpret the list in the context of your specific treatment; do not stop a medicine on your own.
Ask how long visits usually take, whether someone should accompany you, and how to handle travel or care away from the treatment center. If the team provides a treatment alert card, keep it available.
Decisions at reassessment
When results are reviewed, ask what has improved, what remains uncertain, and which options are reasonable next. A decision to continue, pause, or change treatment should connect to both clinical findings and your goals.
If the recommendation is difficult to understand, request a written explanation or another conversation. The useful question is how this particular immunotherapy fits your situation, rather than whether immunotherapy is universally “better” than another treatment.
